GlaxoSmithKline PLC Director/PDMR Shareholding (9616P)
16 October 2019 - 3:00AM
UK Regulatory
TIDMGSK
RNS Number : 9616P
GlaxoSmithKline PLC
15 October 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA')
======================================================================
a) Name Ms E Walmsley
=== ========================= ===========================================
b) Position/status Chief Executive Officer
=== ========================= ===========================================
c) Initial notification/ Initial notification
amendment
=== ========================= ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ======================================================================
a) Name GlaxoSmithKline plc
=== ========================= ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ========================= ===========================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 10 October 2019.
=== ========================= ===========================================
c) Price(s) and volume(s) Price(s) Volume(s)
----------
GBP 16.6032 1469.682
----------
=== ========================= ===========================================
d) Aggregated information N/A (single transaction)
Aggregated volume
Price
=== ========================= ===========================================
e) Date of the transaction 2019-10-11
=== ========================= ===========================================
f) Place of the transaction London Stock Exchange (XLON)
=== ========================= ===========================================
1. Details of PDMR/person closely associated with them ('PCA')
======================================================================
a) Name Mr R Connor
=== ========================= ===========================================
b) Position/status President, Global Vaccines
=== ========================= ===========================================
c) Initial notification/ Initial notification
amendment
=== ========================= ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ======================================================================
a) Name GlaxoSmithKline plc
=== ========================= ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ========================= ===========================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 10 October 2019.
=== ========================= ===========================================
c) Price(s) and volume(s) Price(s) Volume(s)
----------
GBP 16.6032 661.719
----------
=== ========================= ===========================================
d) Aggregated information N/A (single transaction)
Aggregated volume
Price
=== ========================= ===========================================
e) Date of the transaction 2019-10-11
=== ========================= ===========================================
f) Place of the transaction London Stock Exchange (XLON)
=== ========================= ===========================================
1. Details of PDMR/person closely associated with them ('PCA')
======================================================================
a) Name Ms D Conrad
=== ========================= ===========================================
b) Position/status SVP, Human Resources
=== ========================= ===========================================
c) Initial notification/ Initial notification
amendment
=== ========================= ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ======================================================================
a) Name GlaxoSmithKline plc
=== ========================= ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ========================= ===========================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 10 October 2019.
=== ========================= ===========================================
c) Price(s) and volume(s) Price(s) Volume(s)
----------
GBP 16.6032 7.181
----------
=== ========================= ===========================================
d) Aggregated information N/A (single transaction)
Aggregated volume
Price
=== ========================= ===========================================
e) Date of the transaction 2019-10-11
=== ========================= ===========================================
f) Place of the transaction London Stock Exchange (XLON)
=== ========================= ===========================================
1. Details of PDMR/person closely associated with them ('PCA')
======================================================================
a) Name Mr J Ford
=== ========================= ===========================================
b) Position/status SVP & General Counsel
=== ========================= ===========================================
c) Initial notification/ Initial notification
amendment
=== ========================= ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ======================================================================
a) Name GlaxoSmithKline plc
=== ========================= ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ========================= ===========================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 10 October 2019.
=== ========================= ===========================================
c) Price(s) and volume(s) Price(s) Volume(s)
----------
GBP 16.6032 0.000026
----------
=== ========================= ===========================================
d) Aggregated information N/A (single transaction)
Aggregated volume
Price
=== ========================= ===========================================
e) Date of the transaction 2019-10-11
=== ========================= ===========================================
f) Place of the transaction London Stock Exchange (XLON)
=== ========================= ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
==========================================================================
a) Name Mr J Ford
=== ========================= ===============================================
b) Position/status SVP & General Counsel
=== ========================= ===============================================
c) Initial notification/ Initial notification
amendment
=== ========================= ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ========================= ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ========================= ===============================================
b) Nature of the Acquisition of ADSs following the re-investment
transaction of dividends paid to shareholders on 10
October 2019.
=== ========================= ===============================================
c) Price(s) and volume(s) Price(s) Volume(s)
----------
$ 42.2439 0.001
----------
=== ========================= ===============================================
d) Aggregated information N/A (single transaction)
Aggregated volume
Price
=== ========================= ===============================================
e) Date of the transaction 2019-10-11
=== ========================= ===============================================
f) Place of the transaction New York Stock Exchange (XNYS)
=== ========================= ===============================================
1. Details of PDMR/person closely associated with them
('PCA')
======================================================================
a) Name Mr N Hirons
=== ========================= ===========================================
b) Position/status SVP, Global Ethics & Compliance
=== ========================= ===========================================
c) Initial notification/ Initial notification
amendment
=== ========================= ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ======================================================================
a) Name GlaxoSmithKline plc
=== ========================= ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ========================= ===========================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 10 October 2019.
=== ========================= ===========================================
c) Price(s) and volume(s) Price(s) Volume(s)
----------
GBP 16.6032 407.873
----------
=== ========================= ===========================================
d) Aggregated information N/A (single transaction)
Aggregated volume
Price
=== ========================= ===========================================
e) Date of the transaction 2019-10-11
=== ========================= ===========================================
f) Place of the transaction London Stock Exchange (XLON)
=== ========================= ===========================================
1. Details of PDMR/person closely associated with them ('PCA')
==========================================================================
a) Name Mr N Hirons
=== ========================= ===============================================
b) Position/status SVP, Global Ethics & Compliance
=== ========================= ===============================================
c) Initial notification/ Initial notification
amendment
=== ========================= ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ========================= ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ========================= ===============================================
b) Nature of the Acquisition of ADSs following the re-investment
transaction of dividends paid to shareholders on 10
October 2019.
=== ========================= ===============================================
c) Price(s) and volume(s) Price(s) Volume(s)
----------
$ 42.2439 17.449
----------
=== ========================= ===============================================
d) Aggregated information N/A (single transaction)
Aggregated volume
Price
=== ========================= ===============================================
e) Date of the transaction 2019-10-11
=== ========================= ===============================================
f) Place of the transaction New York Stock Exchange (XNYS)
=== ========================= ===============================================
1. Details of PDMR/person closely associated with them ('PCA')
==========================================================================
a) Name Mr D Jackson
=== ========================= ===============================================
b) Position/status PCA of Ms S Jackson (SVP, Global Communications
and CEO Office)
=== ========================= ===============================================
c) Initial notification/ Initial notification
amendment
=== ========================= ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ========================= ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ========================= ===============================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 10 October 2019.
=== ========================= ===============================================
c) Price(s) and volume(s) Price(s) Volume(s)
----------
GBP 16.6032 58.431
----------
=== ========================= ===============================================
d) Aggregated information N/A (single transaction)
Aggregated volume
Price
=== ========================= ===============================================
e) Date of the transaction 2019-10-11
=== ========================= ===============================================
f) Place of the transaction London Stock Exchange (XLON)
=== ========================= ===============================================
1. Details of PDMR/person closely associated with them ('PCA')
======================================================================
a) Name Ms S Jackson
=== ========================= ===========================================
b) Position/status SVP, Global Communications and CEO Office
=== ========================= ===========================================
c) Initial notification/ Initial notification
amendment
=== ========================= ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ======================================================================
a) Name GlaxoSmithKline plc
=== ========================= ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ========================= ===========================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 10 October 2019.
=== ========================= ===========================================
c) Price(s) and volume(s) Price(s) Volume(s)
----------
GBP 16.6032 89.074
----------
=== ========================= ===========================================
d) Aggregated information N/A (single transaction)
Aggregated volume
Price
=== ========================= ===========================================
e) Date of the transaction 2019-10-11
=== ========================= ===========================================
f) Place of the transaction London Stock Exchange (XLON)
=== ========================= ===========================================
1. Details of PDMR/person closely associated with them ('PCA')
==========================================================================
a) Name Mr B McNamara
=== ========================= ===============================================
b) Position/status CEO, GSK Consumer Healthcare
=== ========================= ===============================================
c) Initial notification/ Initial notification
amendment
=== ========================= ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ========================= ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ========================= ===============================================
b) Nature of the Acquisition of ADSs following the re-investment
transaction of dividends paid to shareholders on 10
October 2019.
=== ========================= ===============================================
c) Price(s) and volume(s) Price(s) Volume(s)
----------
$ 42.2439 673.667
----------
=== ========================= ===============================================
d) Aggregated information N/A (single transaction)
Aggregated volume
Price
=== ========================= ===============================================
e) Date of the transaction 2019-10-11
=== ========================= ===============================================
f) Place of the transaction New York Stock Exchange (XNYS)
=== ========================= ===============================================
1. Details of PDMR/person closely associated with them ('PCA')
======================================================================
a) Name Mr D Redfern
=== ========================= ===========================================
b) Position/status Chief Strategy Officer
=== ========================= ===========================================
c) Initial notification/ Initial notification
amendment
=== ========================= ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ======================================================================
a) Name GlaxoSmithKline plc
=== ========================= ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ========================= ===========================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 10 October 2019.
=== ========================= ===========================================
c) Price(s) and volume(s) Price(s) Volume(s)
----------
GBP 16.6032 2433.133
----------
=== ========================= ===========================================
d) Aggregated information N/A (single transaction)
Aggregated volume
Price
=== ========================= ===========================================
e) Date of the transaction 2019-10-11
=== ========================= ===========================================
f) Place of the transaction London Stock Exchange (XLON)
=== ========================= ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
======================================================================
a) Name Mr R Simard
=== ========================= ===========================================
b) Position/status President, Pharmaceuticals Supply Chain
=== ========================= ===========================================
c) Initial notification/ Initial notification
amendment
=== ========================= ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ======================================================================
a) Name GlaxoSmithKline plc
=== ========================= ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ========================= ===========================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 10 October 2019.
=== ========================= ===========================================
c) Price(s) and volume(s) Price(s) Volume(s)
----------
GBP 16.6032 467.749
----------
=== ========================= ===========================================
d) Aggregated information N/A (single transaction)
Aggregated volume
Price
=== ========================= ===========================================
e) Date of the transaction 2019-10-11
=== ========================= ===========================================
f) Place of the transaction London Stock Exchange (XLON)
=== ========================= ===========================================
1. Details of PDMR/person closely associated with them ('PCA')
======================================================================
a) Name Ms K Thomson
=== ========================= ===========================================
b) Position/status PCA of Mr P Thomson (President, Global
Affairs)
=== ========================= ===========================================
c) Initial notification/ Initial notification
amendment
=== ========================= ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ======================================================================
a) Name GlaxoSmithKline plc
=== ========================= ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ========================= ===========================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 10 October 2019.
=== ========================= ===========================================
c) Price(s) and volume(s) Price(s) Volume(s)
----------
GBP 16.6032 121.975
----------
=== ========================= ===========================================
d) Aggregated information N/A (single transaction)
Aggregated volume
Price
=== ========================= ===========================================
e) Date of the transaction 2019-10-11
=== ========================= ===========================================
f) Place of the transaction London Stock Exchange (XLON)
=== ========================= ===========================================
1. Details of PDMR/person closely associated with them ('PCA')
======================================================================
a) Name Mr P Thomson
=== ========================= ===========================================
b) Position/status President, Global Affairs
=== ========================= ===========================================
c) Initial notification/ Initial notification
amendment
=== ========================= ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ======================================================================
a) Name GlaxoSmithKline plc
=== ========================= ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ========================= ===========================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 10 October 2019.
=== ========================= ===========================================
c) Price(s) and volume(s) Price(s) Volume(s)
----------
GBP 16.6032 559.520
----------
=== ========================= ===========================================
d) Aggregated information N/A (single transaction)
Aggregated volume
Price
=== ========================= ===========================================
e) Date of the transaction 2019-10-11
=== ========================= ===========================================
f) Place of the transaction London Stock Exchange (XLON)
=== ========================= ===========================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHLELFFKBFZFBB
(END) Dow Jones Newswires
October 15, 2019 12:00 ET (16:00 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024